PA
Phillip Andrew Dennis sold $6K of NBP stock
Phillip Andrew Dennis, Chief Medical Officer of NovaBridge Biosciences (NBP), sold 8,494 shares of NBP stock worth $6K, per an SEC Form 4 filed Jun 22, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 17, 2026, 5 days before it was made public.
NBP has moved -42.1% since the trade date, from $1.57 to $0.91 (Nov 6, 2026 close).
- Traded
- Jun 17, 2026
- Disclosed
- Jun 22, 2026
- Filing delay
- 5 days
- Price since
- -42.1%
- Role
- Chief Medical Officer
- Source
- SEC Form 4